Table of Contents
Chapter 1:
- Percentage of companies' portfolios supported by patient adherence programs
- Percentage of companies' portfolios supported by disease management
programs
- Functions involved in program development and maintenance
- Program team leadership
- Team sizes throughout program launch and maintenance
- Lifecycle stage in which companies assemble program teams
- Percentage of programs' development budgets that are outsourced
- Percentage of companies outsourcing specific program activities
- Investment in program development from concept to implementation
- Annual program maintenance investment
Chapter 2:
- Percentage of companies that have non-branded disease awareness campaigns
- Percentage of companies leveraging various media channels
- Examples of pharmaceutical adherence tools
- Companies' ratings of program challenges
- Percentage of companies with outcome measurements in place to measure ROI
Chapter 3:
- Percentage of average drugs' foregone sales due to adherence issues
- Brand websites most visited by physicians
Chapter 4 contains 18 program profiles, which each contain the
following metrics and graphics:
- Program background information: condition status, global launch,
brand/therapeutic area peak annual sales
- Percentage of patients compliant at various treatment stages
- Cost to attain a new patient vs. cost to retain an existing patient
- Percentage of current overall marketing budget spent on patient
adherence/disease management
- Program funding sources
- Development budget vs. annual maintenance budget
- Percentage of development budget spent on various program activities
- Media channels leveraged in campaign
- Percentage of development budget that was outsourced
- Staff support at various program stages
- Timing of key program development activities
- ROI measurements
| 
View Cart
